HER2DX® was highlighted in Times 'Medical Care' category, which publicizes inventions that are successfully implemented in medical practice.
This discovery changes the view of the progression of leukaemia, opens the door to early diagnosis, and offers new treatment strategies.
The activity, which is part of a new communication project, allowed visitors to learn about the cancer research carried out by the Institute's resear1
Treatment with trastuzumab deruxtecan, a combination of a targeted therapy with chemotherapy, increases progression-free survival of the disease and1
The Hospital Clínic de Barcelona is consolidating its transorbital surgery programme for patients with skull base tumours. This surgery is led by the1
IDIBAPS publishes more than 300 scientific articles on the disease every year, which represent 22.5% of the total number of publications of the insti1
We speak to Dr. Mertixell Mollà, head of the Radiation Oncology Service and coordinator of the Hospital Clínic Cancer Technical Committee, about the1
A study conducted at Hospital Clínic analysed the genetic profile of more than 300 patients with solid tumours using a liquid biopsy blood test, resu1
• The International Agency for Research on Cancer (IARC) has compiled a review of all the literature written on existing screening and follow-up tech1
Interview with Dr Maria Reig, head of the Hepatic Oncology Unit
